Form 8-K - Current report:
SEC Accession No. 0001140361-25-018514
Filing Date
2025-05-13
Accepted
2025-05-13 09:16:46
Documents
15
Period of Report
2025-05-13
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20048433x3_8k.htm   iXBRL 8-K 52761
2 EXHIBIT 3.1 ny20048433x3_ex3-1.htm EX-3.1 12652
3 EXHIBIT 3.2 ny20048433x3_ex3-2.htm EX-3.2 107870
  Complete submission text file 0001140361-25-018514.txt   347366

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tsvt-20250513.xsd EX-101.SCH 3991
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tsvt-20250513_lab.xml EX-101.LAB 23415
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tsvt-20250513_pre.xml EX-101.PRE 17066
17 EXTRACTED XBRL INSTANCE DOCUMENT ny20048433x3_8k_htm.xml XML 4377
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

EIN.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40791 | Film No.: 25937502
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)